PAA 0.00% 17.0¢ pharmaust limited

Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-123

  1. 2,390 Posts.
    lightbulb Created with Sketch. 1479
    @kpax

    when you can spare a moment, could you briefly comment on Elanco's current VDC 597 mTOR project and any similar current projects that you may be aware of and how they compare to PAAs mpl project. I recall you mentioning them in the past and saying we're way ahead. No rush but it'd be much appreciated.

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.020063

    Last edited by Lastly: 22/07/21
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.000(0.00%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.5¢ 17.5¢ 17.0¢ $21.65K 127.0K

Buyers (Bids)

No. Vol. Price($)
7 326868 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 42638 3
View Market Depth
Last trade - 14.03pm 19/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.